Results 261 to 270 of about 1,216,536 (293)
Some of the next articles are maybe not open access.

CRISPR–Cas in its prime

Nature Reviews Molecular Cell Biology, 2019
CRISPR–Cas9-based prime editing supports the correction of a wide range of mutations, including transversions and insertions and deletions.
openaire   +2 more sources

CRISPR-Cas Systems

2013
Discovery and seminal developments in the CRISPR field.- Occurrence, diversity of CRISPR-Cas systems and genotyping implications.- Evolution and classification of CRISPR-Cas systems and Cas protein families.- Regulation of CRISPR-based immune responses.- crRNA Biogenesis.- Distribution and mechanism of the Type I CRISPR/Cas Systems.- Type II ...
openaire   +1 more source

Structural biology of CRISPR–Cas immunity and genome editing enzymes

Nature Reviews Microbiology, 2022
Patrick Pausch   +2 more
exaly  

CRISPR–Cas adaptive immunity and developments in CRISPR–Cas applications

Physics of Life Reviews, 2014
Edwin L. Cooper, Nicola Overstreet
openaire   +1 more source

Alternative functions of CRISPR–Cas systems in the evolutionary arms race

Nature Reviews Microbiology, 2022
John van der Oost   +2 more
exaly  

RNA-targeting CRISPR–Cas systems

Nature Reviews Microbiology, 2022
Stan J J Brouns   +2 more
exaly  

?????????????????????? ?????????????????????? ???????????? ???? ?????????????????? CRISPR/Cas, ?????? ???? ?????????????????? "?????????????????? ????????????" (?????????????????????? ???????????? ?? ?????????? 2020 ????????)

2021
The Nobel Prize in Chemistry in 2020 was awarded to two researchers in the field of molecular biology: French Emmanuelle Charpentier, who currently heads the Max Planck Unit for the Science of Pathogens (Berlin, Germany), and American Jennifer Doudna of the University of California (Berkeley, CA, USA) ???for the development of a method for genome ...
openaire   +1 more source

CRISPR-Cas for genome editing: Classification, mechanism, designing and applications

International Journal of Biological Macromolecules, 2023
Simran Bhatia
exaly  

Rational designs of in vivo CRISPR-Cas delivery systems

Advanced Drug Delivery Reviews, 2021
Yue Zhang, Jun Wang, Cong-Fei Xu
exaly  

Home - About - Disclaimer - Privacy